Alopecia Areata in Latin America: Where are We and Where are We Going?

被引:2
|
作者
Velasquez-Lopera, Margarita M. [1 ]
Hernandez, Natalia [2 ]
Marie Jansen, Angela [3 ]
Londono Garcia, Angela [4 ]
Carolina Luna, Paula [5 ]
Rico-Restrepo, Mariana [6 ]
del Mar Saez-de-Ocariz, Maria [7 ]
Margarita Tamayo-Buendia, Maria [8 ]
Cecilia Rivitti-Machado, Maria [9 ]
机构
[1] Univ Antioquia, Fac Med, Secc Dermatol, Ctr Invest Dermatol CIDERM, Cra 51D 62-29, Medellin, Colombia
[2] Dermatosoluciones SAS, Bogota, Colombia
[3] Amer Hlth Fdn, Washington, DC USA
[4] CES Univ, Dermatol Dept, Medellin, Colombia
[5] Hosp Aleman, Buenos Aires, DF, Argentina
[6] Amer Hlth Fdn, Bogota, Colombia
[7] Natl Inst Pediat, Dept Dermatol, Mexico City, DF, Mexico
[8] Pontificia Univ Javeriana, Bogota, Colombia
[9] Univ Sao Paulo, Fac Med, Dept Dermatol, Sao Paulo, SP, Brazil
关键词
Alopecia areata; AA treatment; Dermatologic care in LA; Latin America; Targeted therapy in AA; TEC-FAMILY KINASES; QUALITY-OF-LIFE; PREVALENCE; PROFILE; TOFACITINIB; EPIDEMIOLOGY; DISEASE; PATTERN; BURDEN;
D O I
10.1007/s13555-022-00845-4
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Alopecia areata (AA) represents an underrecognized burden in Latin America (LA), severely impacting quality of life (QoL). This impact is exacerbated by limited access to specialized dermatologic care and therapies for AA within and among nations. Many of the unmet needs for AA globally also exist in LA. The region has geographic, ethnic, cultural, and economic conditions. With new AA medicines targeting immunologic pathways on the horizon, LA must prepare regarding regulatory issues, reimbursement, awareness, and education to give adequate and timely treatment for patients with AA. To address these issues, the Americas Health Foundation convened a panel of six dermatologists from Argentina, Brazil, Colombia, and Mexico who are experts in AA and its comorbidities for a 3-day virtual meeting to discuss AA diagnosis and treatment in LA and create a manuscript offering recommendations to address discussed barriers. This publication examines unmet AA needs in LA, treatment, and innovative therapies and recommends improving AA care. Access constraints to conventional and novel medicines hinder appropriate treatments for patients. Therapy initiation delays can affect QoL, mental health, and disease progression. People with AA face stigmas, discrimination, and misconceptions owing to a lack of disease awareness. With promising new treatments for AA on the horizon, all stakeholders must coordinate efforts to enhance LA's AA management landscape and improve patient outcomes.
引用
收藏
页码:95 / 114
页数:20
相关论文
共 50 条
  • [31] Where we are and where we're going
    Falcioni, JG
    MECHANICAL ENGINEERING, 2005, 127 (04) : 4 - 4
  • [32] NUTRITION - WHERE ARE WE . WHERE ARE WE GOING
    HARPER, AE
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1969, 22 (01): : 87 - &
  • [33] 'WHERE ARE WE, WHERE HAVE WE COME FROM, WHERE ARE WE GOING'
    BOLTON, K
    OVERLAND, 1991, (123): : 52 - 53
  • [34] WHERE WERE WE, WHERE ARE WE, WHERE ARE WE GOING, AND WHO CARES
    WOOLSEY, G
    INTERFACES, 1993, 23 (05) : 40 - 46
  • [35] Where have we been? Where are we now? Where are we going?
    Aronoff, GM
    CLINICAL JOURNAL OF PAIN, 1997, 13 (01): : 3 - 5
  • [36] Major Marketing Traditions - Where Are We, Where Are We Going, and Where We Should Be Going and Why?
    Moller, Kristian
    AUSTRALASIAN MARKETING JOURNAL, 2007, 15 (01): : 37 - 38
  • [37] Where We Are and Where We Are Going in Nut Research
    Salas-Salvado, Jordi
    Nishi, Stephanie K.
    Sabate, Joan
    Ros, Emilio
    NUTRIENTS, 2023, 15 (07)
  • [38] Genetics of the epilepsies: where are we and where are we going?
    Helbig, Ingo
    Lowenstein, Daniel H.
    CURRENT OPINION IN NEUROLOGY, 2013, 26 (02) : 179 - 185
  • [39] Obstetric ultrasound: where are we and where are we going?
    Abramowicz, Jacques S.
    ULTRASONOGRAPHY, 2021, 40 (01) : 57 - 74
  • [40] Childhood Stuttering: Where Are We and Where Are We Going?
    Smith, Anne
    Weber, Christine
    SEMINARS IN SPEECH AND LANGUAGE, 2016, 37 (04) : 291 - 297